Back

Effective regurgitant oriffice area vs vena contracta method as predictors of outcomes in severe tricuspid regurgitation.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Mitral and tricuspid Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Ana Garcia Martin

Ramon and Cajal University Hospital, Madrid (Spain)

8 More presentations in this session

Presentation thumbnail
Prognostic value of quantitative assessment of tricuspid regurgitation. Correlation between echocardiography and cardiac magnetic resonance
Mrs R. Hinojar Baydes (Madrid, ES)
Abstract Slides
Presentation thumbnail
Clinical characteristics, diagnosis and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair
Professor P. Lurz (Mainz, DE)
Abstract Slides
Presentation thumbnail
Disease stages of structural and functional cardiac changes associate with outcomes in patients with mitral regurgitation receiving mitral valve intervention
Doctor H. Niikura (Minneapolis, US)
Abstract Slides
Presentation thumbnail
Contemporary trends and outcomes of percutaneous and surgical mitral valve replacement or repair for mitral insufficiency in cancer patients
Doctor A. Guha (Augusta, US)
Abstract Slides
Presentation thumbnail
MitraClip implantation impairs functional echocardiographic parameters of the left atrium in patients with moderate to severe mitral regurgitation
Doctor C. Meindl (Regensburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Mitral and tricuspid

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources